Published in

Elsevier, Pharmacological Research, (136), p. 140-150, 2018

DOI: 10.1016/j.phrs.2018.09.007

Links

Tools

Export citation

Search in Google Scholar

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

Journal article published in 2018 by Laurie S. Conklin, Jesse M. Damsker, Eric P. Hoffman, William J. Jusko, Panteleimon D. Mavroudis, Benjamin D. Schwartz, Laurel J. Mengle-Gaw, Edward C. Smith ORCID, Jean K. Mah ORCID, Michela Guglieri, Yoram Nevo, Nancy Kuntz, Craig M. McDonald ORCID, Mar Tulinius, Monique M. Ryan and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO